About Us

MicroConstants is a GLP-compliant Contract Research Organization (CRO) dedicated to providing premier quality bioanalytical services, IND-enabling drug metabolism (DMPK) assays, ELISA immunoassay, and pharmacokinetic analysis services to pharmaceutical and biotech companies developing new chemical entities (NCEs) worldwide. We specialize in method development, method validation, and sample analysis of small molecules, proteins, and peptides using LC/MS/MS, HPLC/UV, and ELISA for preclinical and clinical drug development studies. MicroConstants also assembles and distributes customized specimen collection kits for all types of clinical trials conducted throughout the world.

MicroConstants, Inc. was founded in 1998 in San Diego, California by Gilbert Lam, Ph.D., a veteran in pharmaceutical development and a scientist trained in the field of pharmacokinetics. Our San Diego facility has since grown to become the largest bioanalytical LC/MS/MS laboratory on the West Coast of the United States housing 16 LC/MS/MS systems and occupying 34,000 square feet of office and laboratory space. We also have an additional 2,000 square feet of off-site archive and storage space in San Diego.

In 2007, MicroConstants expanded its operations internationally when Dr. Lam co-founded MicroConstants China Inc. in Beijing, China to meet the growing demand of pharmaceutical development being outsourced to Asia. MicroConstants China adopted MicroConstants' quality systems and has been GLP-compliant since April 2009.

MicroConstants’ laboratories in San Diego and Beijing are both fully compliant with USFDA, OECD, and MHLW Good Laboratory Practice (GLP) guidelines.

Our Mission

MicroConstants is dedicated to becoming the recognized leader in bioanalytical and pharmacokinetic analysis. We understand that the only way to achieve this goal is by providing our pharmaceutical and biotech partners with the highest quality data, exceptional client services, state-of-art equipment, and a team of skilled professionals. Our success is intertwined with that of our clients’; therefore we constantly strive to meet our customers’ needs, exceed their expectations, and continually expand our contract research services to help advance our clients’ drug discovery and development programs.